$2.27 Billion is the total value of Boxer Capital, LLC's 65 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 17.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | Sell | IMMUNOMEDICS INC | $234,117,000 | +105.5% | 6,606,000 | -21.8% | 10.29% | +32.6% |
| MRTX | MIRATI THERAPEUTICS INC | $201,574,000 | +48.5% | 1,765,560 | 0.0% | 8.86% | -4.2% | |
| BGNE | BEIGENE LTDsponsored adr | $174,270,000 | +53.0% | 925,000 | 0.0% | 7.66% | -1.3% | |
| ODT | ODONATE THERAPEUTICS INC | $142,405,000 | +53.3% | 3,363,377 | 0.0% | 6.26% | -1.1% | |
| RVMD | Sell | REVOLUTION MEDICINES INC | $93,424,000 | +39.8% | 2,959,264 | -3.0% | 4.11% | -9.8% |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $87,188,000 | +55.6% | 2,075,905 | 0.0% | 3.83% | +0.3% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $84,946,000 | +69.0% | 2,014,858 | 0.0% | 3.74% | +9.0% | |
| SGEN | SEATTLE GENETICS INC | $67,968,000 | +47.3% | 400,000 | 0.0% | 2.99% | -5.0% | |
| PASG | Buy | PASSAGE BIO INC | $52,701,000 | +77.7% | 1,928,315 | +2.4% | 2.32% | +14.6% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $51,580,000 | +20.5% | 2,084,883 | -32.4% | 2.27% | -22.3% |
| ESPR | ESPERION THERAPEUTICS INC NE | $50,027,000 | +62.7% | 975,000 | 0.0% | 2.20% | +5.0% | |
| ALLK | ALLAKOS INC | $48,506,000 | +61.5% | 675,000 | 0.0% | 2.13% | +4.2% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $48,440,000 | +438.2% | 7,000,000 | +211.1% | 2.13% | +247.5% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $45,489,000 | +3.4% | 1,094,000 | -28.6% | 2.00% | -33.3% |
| ARGX | Sell | ARGENX SEsponsored adr | $38,498,000 | +46.1% | 170,926 | -14.5% | 1.69% | -5.7% |
| BCEL | ATRECA INC | $36,891,000 | +28.6% | 1,733,583 | 0.0% | 1.62% | -17.0% | |
| PRNB | New | PRINCIPIA BIOPHARMA INC | $36,293,000 | – | 607,000 | +100.0% | 1.60% | – |
| CGEN | COMPUGEN LTDord | $35,803,000 | +106.9% | 2,383,673 | 0.0% | 1.57% | +33.5% | |
| FOLD | AMICUS THERAPEUTICS INC | $35,061,000 | +63.2% | 2,325,000 | 0.0% | 1.54% | +5.3% | |
| QURE | UNIQURE NV | $34,489,000 | -5.0% | 765,400 | 0.0% | 1.52% | -38.7% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $33,905,000 | +325.8% | 2,287,782 | +215.2% | 1.49% | +174.6% |
| GOSS | Buy | GOSSAMER BIO INC | $33,311,000 | +50.2% | 2,562,358 | +17.3% | 1.46% | -3.2% |
| TRILLIUM THERAPEUTICS INC | $32,967,000 | +100.2% | 4,075,000 | 0.0% | 1.45% | +29.1% | ||
| KDMN | KADMON HLDGS INC | $31,774,000 | +22.2% | 6,205,882 | 0.0% | 1.40% | -21.2% | |
| RNA | New | AVIDITY BIOSCIENCES INC | $31,689,000 | – | 1,121,327 | +100.0% | 1.39% | – |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $31,302,000 | +894.0% | 2,202,812 | +188.2% | 1.38% | +540.0% |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $30,882,000 | +12.0% | 7,034,598 | 0.0% | 1.36% | -27.7% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $30,835,000 | +46.0% | 250,000 | 0.0% | 1.36% | -5.8% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $30,684,000 | +50.0% | 1,466,051 | 0.0% | 1.35% | -3.2% | |
| ANAB | ANAPTYSBIO INC | $29,042,000 | +58.1% | 1,300,000 | 0.0% | 1.28% | +2.0% | |
| MRNS | Buy | MARINUS PHARMACEUTICALS INC | $24,384,000 | +150.2% | 9,600,000 | +100.0% | 1.07% | +61.4% |
| LABD | Buy | DIREXION SHS ETF TRdaily s&p biotec | $24,290,000 | +38.0% | 7,000,000 | +460.0% | 1.07% | -11.0% |
| BLU | BELLUS HEALTH INC NEW | $18,265,000 | +3.1% | 1,775,000 | 0.0% | 0.80% | -33.5% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $17,934,000 | +14.7% | 370,000 | 0.0% | 0.79% | -26.0% | |
| CABA | CABALETTA BIO INC | $17,434,000 | +52.5% | 1,566,361 | 0.0% | 0.77% | -1.7% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $16,754,000 | +45.9% | 1,009,255 | 0.0% | 0.74% | -5.9% | |
| PRVL | PREVAIL THERAPEUTICS INC | $16,734,000 | +22.2% | 1,123,105 | 0.0% | 0.74% | -21.1% | |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $15,783,000 | +23.6% | 250,000 | 0.0% | 0.69% | -20.3% | |
| AGEN | AGENUS INC | $15,720,000 | +60.4% | 4,000,000 | 0.0% | 0.69% | +3.4% | |
| KURA | KURA ONCOLOGY INC | $13,770,000 | +63.8% | 844,789 | 0.0% | 0.60% | +5.6% | |
| RLMD | RELMADA THERAPEUTICS INC | $13,425,000 | +31.2% | 300,000 | 0.0% | 0.59% | -15.4% | |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $13,000,000 | – | 1,000,000 | +100.0% | 0.57% | – |
| FULC | New | FULCRUM THERAPEUTICS INC | $12,911,000 | – | 705,882 | +100.0% | 0.57% | – |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $12,331,000 | +381.5% | 4,029,649 | +64.4% | 0.54% | +209.7% |
| MEIP | MEI PHARMA INC | $12,031,000 | +156.5% | 2,913,091 | 0.0% | 0.53% | +65.3% | |
| AKRO | AKERO THERAPEUTICS INC | $10,379,000 | +17.5% | 416,495 | 0.0% | 0.46% | -24.3% | |
| KOD | Buy | KODIAK SCIENCES INC | $9,803,000 | +37.0% | 181,138 | +20.8% | 0.43% | -11.7% |
| SELB | SELECTA BIOSCIENCES INC | $9,327,000 | +17.8% | 3,284,072 | 0.0% | 0.41% | -23.9% | |
| MTNB | MATINAS BIOPHARMA HLDGS INC | $8,873,000 | +28.8% | 11,478,634 | 0.0% | 0.39% | -17.0% | |
| XENE | XENON PHARMACEUTICALS INC | $7,524,000 | +10.6% | 600,000 | 0.0% | 0.33% | -28.7% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $7,404,000 | +64.6% | 290,577 | 0.0% | 0.33% | +6.2% | |
| CBAY | CYMABAY THERAPEUTICS INC | $6,980,000 | +135.8% | 2,000,000 | 0.0% | 0.31% | +52.0% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $6,169,000 | +39.0% | 317,000 | 0.0% | 0.27% | -10.3% | |
| TARA | Buy | ARTARA THERAPEUTICS INC | $6,135,000 | +33.7% | 209,227 | +4.8% | 0.27% | -13.7% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $6,037,000 | – | 126,000 | +100.0% | 0.26% | – |
| ZYME | Buy | ZYMEWORKS INC | $5,952,000 | +571.0% | 165,000 | +560.0% | 0.26% | +336.7% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $5,490,000 | – | 200,000 | +100.0% | 0.24% | – |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $5,088,000 | – | 550,000 | +100.0% | 0.22% | – |
| SLDB | SOLID BIOSCIENCES INC | $4,488,000 | +22.6% | 1,531,872 | 0.0% | 0.20% | -21.2% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $4,166,000 | +105.4% | 1,102,194 | 0.0% | 0.18% | +32.6% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,794,000 | +1.4% | 890,700 | 0.0% | 0.17% | -34.5% | |
| LSACU | LIFESCI ACQUISITION CORPunit 03/31/2025 | $2,988,000 | -0.4% | 300,000 | 0.0% | 0.13% | -35.8% | |
| BLPH | BELLEROPHON THERAPEUTICS INC | $1,240,000 | +14.5% | 98,809 | 0.0% | 0.06% | -25.7% | |
| CLRB | CELLECTAR BIOSCIENCES INC | $1,178,000 | -3.9% | 920,000 | 0.0% | 0.05% | -38.1% | |
| ZGNX | Sell | ZOGENIX INC | $737,000 | -83.0% | 27,300 | -84.4% | 0.03% | -89.2% |
| VXX | Exit | BARCLAYS BK PLCshrt trm etn 48 | $0 | – | -75,000 | -100.0% | -0.24% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.60% | – |
| Exit | BARCLAYS BK PLCput | $0 | – | -300,000 | -100.0% | -0.95% | – | |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -135,000 | -100.0% | -4.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.